Nivolumab,ipilimumab
bms
['/ipi', 'rcc,(-irccs),(-srcc),(-urcc)', 'nivo', 'nivolumab', 'increase,(-increased)', 'ipilimumab']
nivolumab/ipilimumab boosting following nivolumab monotherapy increases responses in advanced rcc #esmo2022 #rcc 
Healthcare publisher of oncology focused articles, videos, panel discussions, and much more that run the gamut of oncology care and management.